Source: iQoncept / Shutterstock
Tenaya Therapeutics (NASDAQ:TNYA) has recently disclosed its financial performance for the last quarter of 2023.
- The company shattered expectations by posting earnings per share of -40 cents, surpassing the projected EPS of -44 cents by analysts.
- In an unconventional move, the quarterly report did not include any revenue figures.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/tnya-stock-earnings-tenaya-therapeutics-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC